Menu
GeneBe

USP37

ubiquitin specific peptidase 37, the group of Ubiquitin specific peptidases

Basic information

Region (hg38): 2:218450250-218568351

Links

ENSG00000135913NCBI:57695OMIM:620226HGNC:20063Uniprot:Q86T82AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the USP37 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the USP37 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
clinvar
2
missense
30
clinvar
2
clinvar
2
clinvar
34
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
1
Total 0 0 30 4 3

Variants in USP37

This is a list of pathogenic ClinVar variants found in the USP37 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-218454943-C-T Benign (Jul 26, 2018)711264
2-218454956-C-T not specified Uncertain significance (Sep 20, 2023)3187531
2-218454995-C-T not specified Uncertain significance (Apr 26, 2023)2507808
2-218455610-C-T not specified Uncertain significance (Oct 26, 2021)2364133
2-218455710-T-C not specified Uncertain significance (Feb 27, 2023)2490033
2-218459787-T-C Likely benign (Sep 01, 2023)2651877
2-218463357-C-T not specified Uncertain significance (Dec 08, 2023)3187530
2-218466107-G-C not specified Uncertain significance (Dec 21, 2023)2372785
2-218466124-G-A Benign (Aug 14, 2017)720766
2-218474666-T-C not specified Likely benign (Oct 13, 2023)3187529
2-218474821-A-C not specified Uncertain significance (Jun 30, 2022)2299574
2-218476866-C-T not specified Uncertain significance (Mar 18, 2024)3331515
2-218479692-T-C not specified Uncertain significance (Sep 16, 2021)2396841
2-218482092-C-A not specified Uncertain significance (Jan 10, 2023)2475218
2-218488351-G-T not specified Uncertain significance (Jan 31, 2022)2274712
2-218488414-C-T Uncertain significance (Sep 01, 2023)2651878
2-218495785-C-T not specified Uncertain significance (Jun 07, 2024)2224569
2-218495803-T-C not specified Uncertain significance (May 27, 2022)2292682
2-218495852-T-G not specified Uncertain significance (May 30, 2024)3331518
2-218495916-T-C not specified Uncertain significance (Dec 05, 2022)2332591
2-218495939-T-C Likely benign (Dec 01, 2022)2651879
2-218497744-T-C not specified Uncertain significance (Oct 26, 2021)2399274
2-218510015-A-C not specified Uncertain significance (Mar 28, 2023)2530388
2-218510021-G-C Benign (Aug 14, 2017)782805
2-218510082-G-T not specified Uncertain significance (May 02, 2024)3331517

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
USP37protein_codingprotein_codingENST00000258399 23118111
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.000006541257300161257460.0000636
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.463455000.6900.00002486439
Missense in Polyphen64149.680.427592061
Synonymous0.8911601750.9140.000008791783
Loss of Function6.28555.50.09010.00000291688

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009360.0000936
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004620.0000462
European (Non-Finnish)0.00008900.0000879
Middle Eastern0.000.00
South Asian0.00009930.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Deubiquitinase that antagonizes the anaphase-promoting complex (APC/C) during G1/S transition by mediating deubiquitination of cyclin-A (CCNA1 and CCNA2), thereby promoting S phase entry. Specifically mediates deubiquitination of 'Lys-11'- linked polyubiquitin chains, a specific ubiquitin-linkage type mediated by the APC/C complex. Also mediates deubiquitination of 'Lys-48'-linked polyubiquitin chains in vitro. Phosphorylation at Ser-628 during G1/S phase maximizes the deubiquitinase activity, leading to prevent degradation of cyclin-A (CCNA1 and CCNA2) (PubMed:21596315). Plays an important role in the regulation of DNA replication by stabilizing the licensing factor CDT1 (PubMed:27296872). {ECO:0000269|PubMed:21596315, ECO:0000269|PubMed:27296872}.;
Pathway
Post-translational protein modification;Metabolism of proteins;Ub-specific processing proteases;Deubiquitination (Consensus)

Recessive Scores

pRec
0.0969

Intolerance Scores

loftool
0.460
rvis_EVS
0.49
rvis_percentile_EVS
79.52

Haploinsufficiency Scores

pHI
0.310
hipred
Y
hipred_score
0.526
ghis
0.540

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.841

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Usp37
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
G1/S transition of mitotic cell cycle;regulation of DNA replication;ubiquitin-dependent protein catabolic process;protein deubiquitination;protein K11-linked deubiquitination;cell division;protein K48-linked deubiquitination
Cellular component
nucleus;nucleoplasm
Molecular function
cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;protein binding;protein kinase binding;thiol-dependent ubiquitinyl hydrolase activity